Second generation inactivated eastern equine encephalitis virus vaccine candidates protect mice against a lethal aerosol challenge.
Currently, there are no FDA-licensed vaccines or therapeutics for eastern equine encephalitis virus (EEEV) for human use. We recently developed several methods to inactivate CVEV1219, a chimeric live-attenuated eastern equine encephalitis virus (EEEV). Dosage and schedule studies were conducted to e...
Main Authors: | Shelley P Honnold, Russell R Bakken, Diana Fisher, Cathleen M Lind, Jeffrey W Cohen, Lori T Eccleston, Kevin B Spurgers, Radha K Maheshwari, Pamela J Glass |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4130539?pdf=render |
Similar Items
-
Role of adhesion molecules and inflammation in Venezuelan equine encephalitis virus infected mouse brain
by: Honnold Shelley P, et al.
Published: (2011-04-01) -
Aerosol infection of Balb/c mice with eastern equine encephalitis virus; susceptibility and lethality
by: Amanda L. Phelps, et al.
Published: (2019-01-01) -
MVA-based vaccines are protective against lethal eastern equine encephalitis virus aerosol challenge in cynomolgus macaques
by: Brandon J. Beddingfield, et al.
Published: (2024-02-01) -
Inactivation of Venezuelan Equine Encephalitis Virus Genome Using Two Methods
by: Mahgol Behnia, et al.
Published: (2022-01-01) -
The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity
by: Maryam Keshtkar-Jahromi, et al.
Published: (2020-11-01)